HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

TCV 309

PAF antagonist
Also Known As:
3-bromo-5-(N-phenyl-N-(2-((2-(1,2,3,4-tetrahydro-2-isoquinolylcarbonyloxy)ethyl)carbamoyl)ethyl)carbamoyl)-1-propylpyridinium nitrate; TCV-309
Networked: 40 relevant articles (5 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dohi, Toshihiro: 2 articles (01/2014 - 10/2004)
2. Morita, Katsuya: 2 articles (01/2014 - 10/2004)
3. Kurata, Yasutaka: 2 articles (12/2007 - 12/2005)
4. Shibamoto, Toshishige: 2 articles (12/2007 - 12/2005)
5. Cui, Sen: 2 articles (12/2007 - 12/2005)
6. Kitayama, Tomoya: 1 article (01/2014)
7. Motoyama, Naoyo: 1 article (01/2014)
8. Kanematsu, Takashi: 1 article (01/2014)
9. Shiraishi, Seiji: 1 article (01/2014)
10. Uezono, Yasuhito: 1 article (01/2014)

Related Diseases

1. Shock
2. Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
3. Pancreatitis
4. Hyperalgesia
5. Stroke (Strokes)

Related Drugs and Biologics

1. Platelet Activating Factor
2. WEB 2086 (apafant)
3. BN 50739
4. Caerulein (Ceruletide)
5. Thromboxane-A Synthase
6. Doxorubicin (Adriamycin)
7. Alprostadil (Muse)
8. ozagrel
9. Ibuprofen (Motrin)
10. pranlukast

Related Therapies and Procedures

1. Warm Ischemia
2. Surgical Portasystemic Shunt (Portosystemic Shunt)
3. Spinal Injections
4. Intravenous Injections
5. Oral Administration